Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that the Company will participate in a fireside chat at the 8th AnnualEvercore Healthcare Conference onTuesday, December 2nd at 2:10 p.m. ET. https://mma.prnewswire.com/media/1273133/Dynavax_Logo.jpg The presentations will be webcast and may be accessed through the “Events & Presentations” page on […]

(NASDAQ:ARTNA), NEWARK, Del., Nov. 19, 2025 (GLOBE NEWSWIRE) — Artesian Resources Corporation (Nasdaq: ARTNA), a leading provider of water and wastewater services, and related services, on the Delmarva Peninsula, today announced that its principal operating subsidiary, Artesian Water Company, Inc. (“Artesian”), received approval from the Delaware Public Service Commission, and support from the Delaware Public

(NASDAQ:CSWC), DALLAS, Nov. 19, 2025 (GLOBE NEWSWIRE) — Capital Southwest Corporation (“Capital Southwest” or the “Company”) (Nasdaq: CSWC), an internally managed business development company focused on providing flexible financing solutions to support the acquisition and growth of middle market businesses, is pleased to announce that its Board of Directors has declared monthly regular dividends of

(NASDAQ:MU), BOISE, Idaho, Nov. 19, 2025 (GLOBE NEWSWIRE) — Micron Technology, Inc. (Nasdaq: MU) announced today that it will hold its fiscal first quarter earnings conference call on Wednesday, Dec. 17, 2025, at 2:30 p.m. Mountain time. The call will be webcast live at http://investors.micron.com/. Webcast replays of presentations can be accessed from Micron's Investor Relations

(NASDAQ:FIVE), PHILADELPHIA, PA, Nov. 19, 2025 (GLOBE NEWSWIRE) — Five Below, Inc. (NASDAQ: FIVE), the trend-right, extreme-value brand for kids, today announced that its financial results for the third quarter of fiscal 2025 will be released after market close on Wednesday, December 3, 2025. The company will host a conference call at 4:30 p.m. Eastern

(NASDAQ:BBIO), PALO ALTO, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that on November 17, 2025, the compensation committee of BridgeBio's board of directors approved equity grants to 12 new employees in restricted stock units

(NASDAQ:CARL), CARLSBAD, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) — Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, Chairman and CEO of Carlsmed, will be presenting at the 37th Annual Piper Sandler Healthcare conference on Wednesday, December 3rd at 9:00-9:25 am ET in New York, NY. During the conference, Carlsmed Management

TEL AVIV, Israel, Nov. 19, 2025 (GLOBE NEWSWIRE) — ImPact Biotech, a clinical-stage biotechnology company focused on developing Padeliporfin vascular targeted photodynamic (VTP) therapy to treat a range of solid tumors, today announced an abstract including updated interim results from ENLIGHTED, the Company's ongoing Phase 3 study of Padeliporfin VTP treatment of patients with low-grade

Five Below, Inc. Announces Third Quarter 2025 Earnings Release and Conference Call Date GlobeNewswire November 19, 2025 PHILADELPHIA, PA, Nov. 19, 2025 (GLOBE NEWSWIRE) — Five Below, Inc. (NASDAQ: FIVE), the trend-right, extreme-value brand for kids, today announced that its financial results for the third quarter of fiscal 2025 will be released after market close

Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference GlobeNewswire November 19, 2025 CARLSBAD, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) — Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, Chairman and CEO of Carlsmed, will be presenting at the 37th Annual Piper Sandler Healthcare conference on Wednesday,